Cells are found throughout sinusoids and conduct phagocytosis of bacteria translocating from the gut
Kupffer Cells
The liver's immune system
Reticuloendothelial system
Responsible for control of ferroportin, vulnerable to excessive cytokine production. This is why inflammatory disease can cause chronic inflammatory anemia
Hepcidin
Mechanism that allows for release of iron from cells
Ferroportin
Circulates to the parietal cells in the body of the stomach to stimulate gastric acid secretion
Gastrin
Secreted by small intestine cells, signals presence of fat digestion products. Circulates to the gall bladder to stimulate contraction and bile secretion
Cholecystokinin (CCK)
Secreted from cells in the ileum, circulate to the stomach to decrease stomach motility and to the pancreas to promote insulin secretion
Glucagon-like peptide 1 (GLP-1)
The nervous system of the gut, rich in opioid peptides and their receptors
Enteric nervous system
Gut's amine secretors
enterochromaffin (EC) cells
Amines secreted by EC cells
Stomach: Histamine (stimulates gastric acid secretion) Small Intestine: Serotonin (increases gastric motility)
Gastric acid producers
Parietal cells
Purpose of low stomach pH (as low as 2)
killing ingested bacteria and activating proteolytic enzyme pepsin
Presence of food in the stomach stimulated gastrin (stimulates gastric acid production and stimulates histamine secretion). Acidification of the stomach lumen inhibits gastrin-secreting cells
Gastric phase
Stomach protections from gastric acid
Mucous neck cells-secrete bicarbonate-rich mucus Prostaglandins-protective (reduce acid secretion, increase mucus secretion, increase mucosal blood flow)
Why do NSAIDs have the potential to damage to GI track?
They inhibit prostaglandin production, thus increasing the risk of acid damage
Risk factors for peptic ulcers
hyperacidity, smoking, reflux of small intestine bile acids or digestive enzymes in to stomach, NSAIDs
Why does smoking increase risk of peptic ulcers?
Decreases gastric mucosal blood flow (increased opportunity for damage and slower healing)
Risk factors for pancreatitis
Alcohol use, gallstones and drug reactions
Functions potentially impacted by pancreatitis
Bicarbonate and insulin production
End products of digestion
Starches, proteins, triglycerides, phospholipids, cholesterol esters
Types of diarrhea
1. secretory (cholera) 2.malabsorptive (celiac) 3.inflammatory (IBS) 4.osmotic (lactose intolerance)
Common immune-based gut disorder
Celiac disease
MoA in Celiac Disease
Basically, pathologic immune activation (lymphocytes, dendritic cells, and cytokine milieu). Basically a hypersensitivity reaction to gluten
Risk factor for Inflammatory Bowel Diseases
Family history and diagnosis of another autoimmune disease
Two common inflammatory bowel diseases
Chron's disease and ulcerative colitis
Symptoms of inflammatory bowel diseases
abdominal pain, frequent diarrhea, rectal bleeding, anemia
Symptoms that can distinguish Chron's from UC
Chron's: relapsing/remitting abd pain, skip legions (especially in the ileum) fistulas UC: More blood loss
Pathology of IBS
We don't know
Most efficient IBS treatment
Pattern tracking and avoiding triggers
Inheriting the autosomal dominant mutation for this increases your risk of multiple forms of cancer (stomach, hepatobiliary, small intestine, renal pelvis, ureter and endometrial/ovarian (in females)) and is the only way for you to get non-polyposis colorectal cancer.
Lynch syndrome
Common microbial causes for pediatric gastroenteritis
Viral: Rotavirus (preventable by vaccination) and norovirus Parasitic: Giardia or Cryptosporidium
Differentiating between Infantile Gastroesophageal Reflux (GER) and Infant and pediatric Gastroesophageal Reflux Disease (GERD)
GER: Presents in the infant period and typically resolves by 12 months, painless
GERD: Can present at any time, pain, recurrent vomiting, dysphagia, and food refusal
This disease is cause by lack of innervation by enteric nerves and typically requires surgical resection. Typical manifestation is failure to produce a bowel movement after birth
Hirschsprung disease
Gerontologic GI considerations
Higher incidence of GI symptoms, problems with mouth, teeth and decreasing muscle and sphincter tone increase risk for aspiration, d/t anatomy diverticular disease is more common
Blood flow and the liver
High rate of blood flow. About 20-25% of cardiac output. Two main blood sources are the portal vein (deoxygenated, about 75-80% of hepatic bf) and the hepatic artery (source of oxygenated blood)
Physiologic considerations with the liver
1. large role in metabolism 2. produces bile (needed for fat digestion/absorption) 3. Protein synthesis (most plasma proteins) 4. Biotransformation of bilirubin 5. Drug metabolism 6. production of clotting factors 7. Vulnerable to infection (hepatitis) and damage
The liver and bilirubin metabolism
The heme created by the breakdown of RBCs is converted to bilirubin. Bilirubin attaches to albumin (indirect bilirubin) for transport. Indirect bilirubin cannot be excreted by the body, so liver cells convert it to direct bilirubin by conjugating it to glucuronic acid. Direct bilirubin can travel freely in the blood and is secreted into bile (and bile is secreted into the intestines and excreted as stool). Bilirubin gives bile and stool it's color.
Two outcomes during first pass drug metabolism
1. Inactivated by the liver: dosage must reflect this 2.Prodrugs- activated by liver metabolism
Adjustment of drug dosing in liver disease
Hepatic dosing- (depending on first pass drug metabolism liver disease could result in a medication not being effective or OD at a normal dose)
Mediators of liver metabolism
Insulin and glucagon
Roles of liver in metabolism
Excess glucose stored as glycogen or synthesized into triglycerides (which can be packaged as VLDL), can also produce glucose from glycogen during fasting, also synthesizes cholesterol
Additional features of the liver
1. Vitamin and mineral storage (vitamins A, E and B12), also iron storage as ferritin, synthesis of transferrin (iron-binding and regulating) and hepcidin 2. Regenerative capacity (complete restoration of function after mild-moderate liver damage and ability to use living donors)
Most specific liver marker, biproduct of liver cell necrosis
Alanine aminotransferase (ALT)
Considerations in Acute liver disease
1. >50% of cases are caused by drug-induced liver injury 2. Prodrome symptoms (fatigue and nausea) which can resolve spontaneously 3. Appearance of jaundice indicates more severe insult
Disease that presents with blockage of bile flow
Acute cholestasis
Symptoms of acute cholestasis
Jaundice (hyperbilirubinemia), elevated GGT, ALP, increased circulating bile salts (itching (pruritis) indicate cutaneous deposition of bile salts), pale stools, and dark urine.
General term for liver inflammation
Hepatitis
Considerations with different types of viral hepatisis
Hep A: Oral-fecal transmission Hep B: no cure, only prevention by vaccine Hep C: often asymptomatic. Now curable with an expensive medication
Hereditary disease whose pathology is the inverse of the pathology of chronic inflammatory anemia (too much hepcidin activity)
Hereditary hemochromatosis
Management of nonalcoholic fatty liver disease in children
Similar to adults- weight reduction (through lifestyle changes or medical management)
Gerontologic considerations for the liver
1. Decreased bf and liver mass 2. high rates of polypharmacy (often multiple providers) 3. Increased incidence of autoimmune damage (autoimmune hepatitis and primary biliary cholangitis)
Hepatitis A incubation period
about 4 weeks
Viral infection that can lead to hepatocellular carcinoma
Hepatitis C